Abstract
Aim
Analgesic and anti-inflammatory drugs are frequently prescribed in paediatrics. Prescribing and dosing patterns in hospitalised children are not well known. This study explores analgesic drug utilisation on five paediatric wards and discusses its findings in comparison with World Health Organization (WHO) guidelines.
Method
A sub-analysis of a prospective, multicentre, observational cohort study was undertaken. Prescription data of children aged up to ≤18 years were collected between October 2008 and December 2009 on paediatric general medical wards in five hospitals in Australia, Germany, the United Kingdom (UK), Hong Kong (HK) and Malaysia. Analgesic drug prescriptions were analysed for prescribing patterns in terms of dosing, frequency and route of administration. Dosing data were compared with local recommendations and WHO guidelines for children.
Results
In the study cohort, 56.8 % (726/1278) of paediatric patients received at least one analgesic drug prescription (1227 prescriptions). The median age of patients with analgesics was 2.2 years [interquartile range (IQR) 0.8–7.3], and the median number of prescriptions per patient was one (IQR 1–2). The most commonly prescribed drugs were oral paracetamol (45.9 %, 563/1227) and oral ibuprofen (19.9 %, 244/1227). Daily doses of paracetamol ranged from 30 mg/kg/day in Germany to 67–68 mg/kg/day in the UK and HK (p < 0.05). For ibuprofen, single doses ranged from 5–6 mg/kg in HK and the UK to 10 mg/kg in Germany and Australia (p < 0.001). Opioid use prevalence was statistically different between the centres and ranged from 0 to 17.6 % (p < 0.001).
Conclusion
This study provides a comprehensive overview of analgesic drug use of hospitalised children. Similar to primary care data, paracetamol is the most commonly used analgesic. As recommended by WHO guidelines, oral medication was favoured and opioids used in addition to paracetamol and ibuprofen. Overall drug utilisation was in line with local recommendations and WHO guidelines. Differences in use of paracetamol and ibuprofen among countries were seen, indicating that safety concerns are perceived differently. More large-scale safety studies are needed.
Similar content being viewed by others
References
Cummings EA, Reid GJ, Finley GA, McGrath PJ, Ritchie JA. Prevalence and source of pain in pediatric inpatients. Pain. 1996;68(1):25–31.
Ellis JA, O’Connor BV, Cappelli M, Goodman JT, Blouin R, Reid CW. Pain in hospitalized pediatric patients: how are we doing? Clin J Pain. 2002;18(4):262–9.
Groenewald CB, Rabbitts JA, Schroeder DR, Harrison TE. Prevalence of moderate-severe pain in hospitalized children. Paediatr Anaesth. 2012;22(7):661–8.
Johnston CC, Abbott FV, Gray-Donald K, Jeans ME. A survey of pain in hospitalized patients aged 4–14 years. Clin J Pain. 1992;8(2):154–63.
Karling M, Renstrom M, Ljungman G. Acute and postoperative pain in children: a Swedish nationwide survey. Acta Paediatr. 2002;91(6):660–6.
Schechter NL, Allen DA, Hanson K. Status of pediatric pain control: a comparison of hospital analgesic usage in children and adults. Pediatrics. 1986;77(1):11–5.
Walco GA, Cassidy RC, Schechter NL. Pain, hurt, and harm. The ethics of pain control in infants and children. N Engl J Med. 1994;331(8):541–4.
Twycross A, Collis S. How well is acute pain in children managed? A snapshot in one English hospital. Pain Manag Nurs. 2013;14(4):e204–15.
Stevens BJ, Harrison D, Rashotte J, Yamada J, Abbott LK, Coburn G, et al. Pain assessment and intensity in hospitalized children in Canada. J Pain. 2012;13(9):857–65.
Birnie KA, Chambers CT, Fernandez CV, Forgeron PA, Latimer MA, McGrath PJ, et al. Hospitalized children continue to report undertreated and preventable pain. Pain Res Manag. 2014;19(4):198–204.
Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med. 2002;347(14):1094–103.
Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet. 1997;349(9052):599–603.
World Health Organization. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. Geneva: World Health Organization; 2012.
Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, et al. Drug use in children: cohort study in three European countries. BMJ. 2008;337:a2245.
Neubert A, Verhamme K, Murray ML, Picelli G, Hsia Y, Sen FE, et al. The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands. Pharmacol Res. 2010;62(3):243–8.
Rashed AN, Wong IC, Cranswick N, Hefele B, Tomlin S, Jackman J, et al. Adverse Drug Reactions in Children-International Surveillance and Evaluation (ADVISE): a multicentre cohort study. Drug Saf. 2012;35(6):481–94.
Rashed AN, Wong IC, Cranswick N, Tomlin S, Rascher W, Neubert A. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study. Eur J Clin Pharmacol. 2012;68(5):801–10.
Rashed AN, Wong IC, Wilton L, Tomlin S, Neubert A. Drug utilisation patterns in children admitted to a paediatric general medical ward in five countries. Drugs Real World Outcomes. 2015;2(4):397–410.
The Royal Children’s Hospital Melbourne. Clinical practice guidelines—drug doses. http://ww2.rch.org.au/clinicalguide/forms/drugDoses.cfm. Accessed 16 Sept 2016.
Rote Liste Service GmbH. Fachinfo-Service: SPC ben-u-ron® Saft. http://www.fachinfo.de/. Accessed 16 Sept 2016.
Paediatric Formulary Committee. BNF for Children (BNFC) 2014–2015. London: BMJ Group, Pharmaceutical Press, and RCPCH Publications; 2014.
Taketomo CK, Hodding J, Kraus D. Pediatric and neonatal dosage handbook. Hudson: Lexi-Comp; 2012.
Rote Liste Service GmbH. Fachinfo-Service: SPC Dolormin® für Kinder Ibuprofensaft 2 %. http://www.fachinfo.de/. Accessed 16 Sept 2016.
O’Donnell FT, Rosen KR. Pediatric pain management: a review. Mo Med. 2014;111(3):231–7.
Brune K, Renner B, Tiegs G. Acetaminophen/paracetamol: a history of errors, failures and false decisions. Eur J Pain. 2015;19(7):953–65.
Ärzteblatt online. Paracetamol: Ab zehn Gramm nur noch auf Rezept (paracetamol: from ten grams upwards only with prescription). http://www.aerzteblatt.de/nachrichten/35993/Paracetamol-Ab-zehn-Gramm-nur-noch-auf-Rezept. Accessed 16 Sept 2016.
BNF for Children. Why have the paracetamol doses in postoperative pain changed? https://www.evidence.nhs.uk/formulary/bnfc/current/frequently-asked-questionsclinical/central-nervous-system/why-have-the-paracetamol-doses-in-postoperative-pain-changed. Accessed 16 Sept 2016.
Marzuillo P, Guarino S, Barbi E. Paracetamol: a focus for the general pediatrician. Eur J Pediatr. 2014;173(4):415–25.
Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: a meta-analysis. Arch Pediatr Adolesc Med. 2004;158(6):521–6.
Smith C, Goldman RD. Alternating acetaminophen and ibuprofen for pain in children. Can Fam Physician. 2012;58(6):645–7.
Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, et al. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Cochrane Database Syst Rev. 2013;(10):Cd009572.
Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011;127(3):580–7.
Zernikow B, Hechler T. Pain therapy in children and adolescents. Dtsch Arztebl Int. 2008;105(28–29):511–21.
Blaser LS, Tramonti A, Egger P, Haschke M, Krahenbuhl S, Ratz Bravo AE. Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol. 2015;71(2):209–17.
Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M, et al. Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol. 2015;71(2):219–27.
Rollason V, Desmeules JA. Use of metamizole in children and the risk of agranulocytosis: is the benefit worth the risk? Eur J Anaesthesiol. 2015;32(12):837–8.
Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA, et al. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children—a prospective observational cohort study of 6601 admissions. BMC Med. 2013;11:237.
Marzuillo P, Calligaris L, Barbi E. Tramadol can selectively manage moderate pain in children following European advice limiting codeine use. Acta Paediatr. 2014;103(11):1110–6.
European Medicines Agency (EMA). Paediatric investigation plan for tapentadol (EMEA-000495-PIP01-08-M09). http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/pips/EMEA-000495-PIP01-08-M09/pip_000028.jsp&mid=WC0b01ac058001d129. Accessed 16 Sept 2016.
ClinicalTrials.gov. Use of tapentadol oral solution for pain after surgery in children from newborn to less than 2 years old. https://clinicaltrials.gov/ct2/show/NCT02221674. Accessed 16 Sept 2016.
Acknowledgments
We would like to thank Ann-Kathrin Oehme and Wolfgang Rascher (Germany), Siew Siang Chua and Norrashidah Bt Abdul Wahab (Malaysia), Noel Cranswick and Valerie Sung (Australia), and Kenneth Lee and Tsui Ha Chan (Hong Kong) for their help with the data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
SB, AR, IW, ST and AN have declared that they have no financial interests that may be relevant to the submitted work.
Funding
AR was funded by the Yamani Cultural and Charitable Foundation, London, UK.
Ethical approval and informed consent
The study protocol was reviewed and approved by the appropriate national research ethics committee in each participating country and has been performed in accordance with the ethical standards of the Declaration of Helsinki. As this was an observational study, involving intensive chart review, no direct contact with patients or informed consent was required. Only anonymised data was recorded, which cannot be traced to individual patients.
Rights and permissions
About this article
Cite this article
Botzenhardt, S., Rashed, A.N., Wong, I.C.K. et al. Analgesic Drug Prescription Patterns on Five International Paediatric Wards. Pediatr Drugs 18, 465–473 (2016). https://doi.org/10.1007/s40272-016-0198-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-016-0198-9